第二阶段反应：葡萄糖醛酸化

Glucuronidation is a phase II biotransformation reaction that conjugates glucuronic acid to drugs or xenobiotics, making them more water-soluble and easier to excrete. This process is considered the most crucial phase II reaction because it significantly enhances drug hydrophilicity, facilitating detoxification and urinary elimination. UDP-glucuronosyltransferases (UGTs) are the enzymes that catalyze this essential metabolic pathway.

UGT enzymes bind to both the substrate and UDP-glucuronic acid, then transfer the glucuronic acid moiety to a functional group on the substrate. This activated coenzyme mechanism produces a glucuronide conjugate that is more polar and readily excreted by the kidneys. The reaction requires the synthesis of an activated coenzyme before the glucuronyl transfer occurs.

Glucuronides are classified by their conjugation site: O-glucuronides form when glucuronic acid binds to oxygen in hydroxyl or carboxylic acid groups; N-glucuronides form with nitrogen in amine, amide, or sulfonamide groups; S-glucuronides form with thiolic sulfur; and C-glucuronides form with nucleophilic carbon. Each type results from the glucuronyl moiety attaching to different functional groups on the substrate.

Acetaminophen, morphine, and ibuprofen are commonly metabolized via glucuronidation. Acetaminophen is converted to a glucuronide conjugate before urinary excretion, morphine transforms into morphine-3-glucuronide, and ibuprofen becomes an inactive glucuronide conjugate. Antidepressants like amitriptyline and HIV medications such as raltegravir also undergo this phase II reaction.

Glucuronidation increases drug polarity by adding a hydrophilic glucuronic acid moiety, transforming lipophilic compounds into water-soluble metabolites. These polar glucuronide conjugates are rapidly recognized and excreted by the kidneys, preventing drug accumulation and reducing potential toxicity. The enhanced hydrophilicity is the key mechanism enabling efficient renal elimination.

Glucuronidation is abundant in body tissues and is closely associated with microsomal mixed-function oxidases. The process employs D-glucuronic acid derived endogenously from D-glucose, making it a widespread metabolic capability. This abundance across tissues ensures that glucuronidation can process diverse xenobiotics and drug metabolites efficiently.

Glucuronidation is one of several phase II conjugation reactions that modify drugs to enhance excretion. While other phase II reactions include phase II reactions glutathione conjugation and mercapturic acid formation and phase reactions sulfation and conjugation with amino acids, glucuronidation is considered the most important due to its widespread occurrence and capacity to metabolize drugs across multiple therapeutic classes.